CompletedPhase 3NCT02336477

Mexiletine and Non Dystrophic Myotonias

Studying Thomsen and Becker disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Assistance Publique - Hôpitaux de Paris
Principal Investigator
Bertrand Fontaine, MD, PhD
Assistance Publique Hopitaux de Paris
Intervention
Mexiletine(drug)
Enrollment
24 enrolled
Eligibility
18-65 years · All sexes
Timeline
2011 – 2014

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02336477 on ClinicalTrials.gov

Other trials for Thomsen and Becker disease

Additional recruiting or active studies for the same condition.

See all trials for Thomsen and Becker disease →

← Back to all trials